Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 2.221\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCC(C)(C(=O)NC1CCCC1)N(Cc1cccs1)C(=O)c1ccc2c(c1)OCO2
b. CCCn1c(=O)[nH]c(=O)c2c(C(F)(F)F)cc(-c3ccc(C)cc3)nc21
c. O=c1c2ccccc2[nH]c(=S)n1Cc1ccc2c(c1)OCO2
d. O=C(c1ccccc1)N1CCN(CC#CC2(O)CCCCC2)CC1
e. CC(C)N1C(=O)CSC1c1ccc(Br)cc1
Answer: a. CCC(C)(C(=O)NC1CCCC1)N(Cc1cccs1)C(=O)c1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C(=O)NC1CCCC1)N(Cc1cccs1)C(=O)c1ccc2c(c1)OCO2
CCC(C)(C(=O)NC1CCCC1)N(Cc1cccs1)C(=O)c1ccc2c(c1)OCO2
N-[1-(cyclopentylamino)-2-methyl-1-oxobutan-2-yl]-N-(thiophen-2-ylmethyl)-1,3-benzodioxole-5-carboxamide